AbbVie
ABBV
#28
Rank
โ‚ฌ332.71 B
Marketcap
188,11ย โ‚ฌ
Share price
2.05%
Change (1 day)
-1.33%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of December 2025 : โ‚ฌ58.37 Billion

According to AbbVie's latest financial reports the company's total debt is โ‚ฌ58.37 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ57.45 B-10.95%
2024-12-31โ‚ฌ64.52 B20.11%
2023-12-31โ‚ฌ53.71 B-8.93%
2022-12-31โ‚ฌ58.98 B-12.89%
2021-12-31โ‚ฌ67.71 B-3.22%
2020-12-31โ‚ฌ69.96 B17.46%
2019-12-31โ‚ฌ59.56 B69.05%
2018-12-31โ‚ฌ35.23 B13.14%
2017-12-31โ‚ฌ31.14 B-11.08%
2016-12-31โ‚ฌ35.02 B20.92%
2015-12-31โ‚ฌ28.96 B135.22%
2014-12-31โ‚ฌ12.31 B15.51%
2013-12-31โ‚ฌ10.66 B-10.02%
2012-12-31โ‚ฌ11.84 B31954.69%
2011-12-31โ‚ฌ36.96 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚ฌ55.31 B-5.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ36.76 B-37.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ47.22 B-19.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ5.68 B-90.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ21.56 B-63.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.77 B-30.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ25.21 B-56.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ20.63 B-64.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.35 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA